Clinical experiments have shown that a prescription drug designed specifically to cure premature ejaculation PE, can triple the amount of time men can last before ejaculating.

According to Men's Health magazine, the pill named 'Priligy' is already available in the European market and may shortly be brought before the Food and Drug Administration for sanction in United States.

In 2009, Johnson & Johnson started selling the drugs in Germany, Spain and Italy, but the Food and Drug Administration refused J&J's application in the year 2005.

While Priligy may solve many men's bedroom issues, some scientists fear that a wide-ranging advertising campaign for the pill could incite fearfulness in men who don't have a medical problem.

Joel Lexchin, a professor of health policy at the York University in Toronto, told Men''s Health, stated, "There are tons of men out there who think they should be doing better and who will buy into a PE campaign."

"It could implicitly or explicitly define what PE means so that any man could identify with the condition," Prof. Joel added. (With Input from Agencies)